LUMIRACOXIB

Lumiracoxib is a COX2 selective inhibitor reducing inflammation with potentially fewer GI effects. Side effects include liver toxicity, edema, and hypertension. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 8ec670c7871e Category: Tag:

Product Description


Mechanism of Action

LUMIRACOXIB exhibits a multilayered biochemical interaction profile involving modulation of enzyme cascades, receptorregulated signalling, mitochondrial bioenergetics, redoxstate equilibrium, membranepotential dynamics and transcriptionfactor activation. Depending on concentration and cellular context, the compound can influence phosphorylation cycles, alter calcium signalling thresholds, disrupt or stabilise cytoskeletal structures, and reprogram metabolic flux pathways.

Benefits and Advantages

This compound is widely used in advanced mechanistic research, including:

  • Receptorligand interaction analysis and allostericbinding studies
  • Enzymekinetic mapping and catalyticdomain investigation
  • Mitochondrialfunction, ROSbalance and redoxmodulation assays
  • Transcriptomic, proteomic and metabolomic profiling
  • Cellularstress signalling, apoptosis/autophagy modelling and membranedynamics studies
  • Pharmacodynamic simulation, SAR evaluation and earlystage compound screening

Side Effects and Risks

Possible risks include mitochondrial overload, oxidativestress imbalance, ionchannel disruption, metabolic pathway misregulation, receptor crosstalk, and dosedependent cytotoxicity. At higher exposure, apoptosis, autophagy, transcriptional destabilisation or inflammationpathway activation may occur. Use only with strict laboratory safety procedures.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C15H13ClFNO2

Molecular Weight

293.72 g/mol

CAS Number

220991-20-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

5.49e-03 g/L

Purity

Purity information is available upon request (COA).

Synonym

Lumiracoxib; 220991-20-8; Prexige; COX-189; 2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid

IUPAC/Chemical Name

2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid

InChl Key

KHPKQFYUPIUARC-UHFFFAOYSA-N

InChl Code

InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)

References

https://pubchem.ncbi.nlm.nih.gov/compound/151166;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download